We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+1.91%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.7B
AUM Growth
+$101M
Cap. Flow
+$158M
Cap. Flow %
1.07%
Top 10 Hldgs %
22.11%
Holding
946
New
64
Increased
332
Reduced
304
Closed
69

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$57.5M
2
AZN icon
AstraZeneca
AZN
+$44.9M
3
ADSK icon
Autodesk
ADSK
+$43.5M
4
MELI icon
Mercado Libre
MELI
+$40.7M
5
AMGN icon
Amgen
AMGN
+$33.6M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$92.5M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$88M
3
BABA icon
Alibaba
BABA
+$73.8M
4
MRK icon
Merck
MRK
+$49.8M
5
MXIM
Maxim Integrated Products
MXIM
+$48.5M

Sector Composition

Rank Sector Weight
1 Healthcare 32.09%
2 Technology 24.53%
3 Financials 9.08%
4 Communication Services 8.24%
5 Consumer Discretionary 7.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DOV icon
501
Dover
DOV
$26.9B
$2.8M 0.02%
18,004
-1,561
-8% -$259K
EOG icon
502
EOG Resources
EOG
$77.3B
$2.79M 0.02%
34,735
– –
MRVL icon
503
Marvell Technology
MRVL
$158B
$2.77M 0.02%
46,011
-1,851
-4% -$111K
PPG icon
504
PPG Industries
PPG
$25.1B
$2.74M 0.02%
19,152
-74,890
-80% -$12M
AIZ icon
505
Assurant
AIZ
$14B
$2.71M 0.02%
17,204
+6,312
+58% +$1.02M
LII icon
506
Lennox International
LII
$15.1B
$2.71M 0.02%
9,218
– –
DVA icon
507
DaVita
DVA
$15.5B
$2.71M 0.02%
23,288
-42,489
-65% -$5.32M
ATO icon
508
Atmos Energy
ATO
$29.7B
$2.7M 0.02%
30,592
-40,649
-57% -$3.93M
WMB icon
509
Williams Companies
WMB
$85.9B
$2.61M 0.02%
100,775
+4,492
+5% +$113K
SYRS
510
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$2.61M 0.02%
58,427
– –
MSCI icon
511
MSCI
MSCI
$42.6B
$2.61M 0.02%
4,292
-266
-6% -$163K
SPG icon
512
Simon Property Group
SPG
$77B
$2.61M 0.02%
20,062
-4
-0% -$521
AZO icon
513
AutoZone
AZO
$51.6B
$2.59M 0.02%
1,523
-19
-1% -$30.5K
AME icon
514
Ametek
AME
$54.9B
$2.57M 0.02%
20,695
-3,767
-15% -$506K
CTAS icon
515
Cintas
CTAS
$87.2B
$2.55M 0.02%
26,836
-2,312
-8% -$226K
VFC icon
516
VF Corp
VFC
$5.91B
$2.54M 0.02%
37,937
-296,834
-89% -$22.8M
XRAY icon
517
Dentsply Sirona
XRAY
$2.88B
$2.54M 0.02%
43,727
+27,515
+170% +$1.7M
APH icon
518
Amphenol
APH
$190B
$2.54M 0.02%
69,226
-13,512
-16% -$496K
PEG icon
519
Public Service Enterprise Group
PEG
$38.7B
$2.54M 0.02%
41,631
+1,251
+3% +$78.1K
CTSH icon
520
Cognizant
CTSH
$26.5B
$2.53M 0.02%
34,075
-3,038
-8% -$224K
HIG icon
521
Hartford Financial Services
HIG
$39.8B
$2.52M 0.02%
35,848
– –
FOE
522
DELISTED
Ferro Corporation
FOE
$2.52M 0.02%
123,663
– –
QRVO icon
523
Qorvo
QRVO
$8.07B
$2.51M 0.02%
15,029
-112,734
-88% -$20.9M
JNCE
524
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$2.51M 0.02%
337,398
– –
GPN icon
525
Global Payments
GPN
$24.2B
$2.48M 0.02%
15,766
-377
-2% -$65.5K
19 20
21
22 23

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2021 Portfolio in Review

As of Q3 2021, Candriam SCA held 946 positions worth $14.7B, up 0.69% from $14.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA's Q3 2021 filing shows 64 new, 332 increased, 304 reduced and 69 closed positions. Its largest new stake was FIVE9: 86,075 shares worth $13.7M. The largest sale was Alexion Pharmaceuticals, an estimated $92.5M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q3 2021 buy was FIVE9: 86,075 shares worth $13.7M.
  • Candriam SCA added most to Johnson & Johnson in Q3 2021, an estimated $57.5M increase.
  • Candriam SCA's biggest Q3 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $88M.
  • Candriam SCA fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $92.5M.
  • Candriam SCA's ten largest holdings make up 22% of its $14.7B portfolio in Q3 2021.
  • Candriam SCA opened 64 new positions and closed 69 in Q3 2021.
  • Candriam SCA's portfolio value rose 0.69% quarter-over-quarter to $14.7B.

Based on Candriam SCA's 13F filing for Q3 2021, filed 9 Nov 2021.